Mark Brantly
Emeritus Professor · University of Florida College of Medicine
Credentials: · ·
History
- 1982–1984
Pulmonary Disease
- 1979–1982
Internal Medicine
Research
Efficacy and safety of sirolimus in lymphangioleiomyomatosis
New England Journal of Medicine · 2011 · 858 citations
Nature Genetics · 1996 · 475 citations
Molecular basis of alpha-1-antitrypsin deficiency
Review · The American Journal of Medicine · 1988 · First of 3 authors · 432 citations
29 papers
21 papers
- JS
20 papers
- RS
20 papers
- AB
15 papers
- GT
14 papers
- EE
13 papers
12 papers
Grants
- 2003–2009
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $1.3M · University of Florida
- 2002–2007
Anti-Inflammatory Role of Alpha-1 Antitrypsin in Lung
National Heart, Lung, and Blood Institute · K24
Contact PI · $670.5K · University of Florida
Clinical trials
- 2018–2021
Long-Term Follow-up Study of ADVM-043
Principal investigator · Completed
Adverum Biotechnologies, Inc.
- 2017–2019
Safety Dose Finding Study of ADVM-043 Gene Therapy to Treat Alpha-1 Antitrypsin (A1AT) Deficiency
Principal investigator · Completed · Phase 1, Phase 2
Adverum Biotechnologies, Inc.
- 2017–2019
Assessment of Satiety Following Oral Administration of an Erythritol Sweetened Beverage
Principal investigator · Completed
University of Florida
- 2016–2019
Effect of Obesity on Immune Response to Pneumovax 23
Principal investigator · Completed
University of Florida